Is health status impaired in childhood cancer survivors? A systematic review and meta-analysis
Introduction
Treatment advances for childhood cancer have improved considerably over the last decades, with an overall 5-year survival of ˜80% (Ward et al., 2014). The prevalence of childhood cancer survivors (CCS) is therefore increasing, with the total number of CCS estimated to reach 500,000 in the United States by 2020 (Robison and Hudson, 2014). However, the increase in survival rates is not necessarily associated with a good health status after disease recovery, and can impose significant medical burdens. Indeed, conventional anti-cancer treatments (chemotherapy and/or radiotherapy) can induce late effects in adult survivors of childhood cancer and thus be associated with long-term health issues (Lipshultz et al., 1991; Oeffinger et al., 2000), which need to be monitored (Ward et al., 2014). Further, intensification of traditional treatments is likely to induce marginal benefits while further aggravating adverse effects, which drives the development of new targeted therapy strategies (e.g., immunotherapy) (Burdach et al., 2018).
Approximately 62% of CCS will have at least one chronic disease 30 years after the first diagnosis (Oeffinger et al., 2006), and a higher incidence of a severe, disabling, life-threatening, or fatal health condition has been reported in CCS as compared with their siblings (Armstrong et al., 2014). Notably, cardiac abnormalities (Adams et al., 2004; Landy et al., 2013; Lipshultz et al., 2012), pulmonary complications (Dietz et al., 2016), diabetes (Meacham et al., 2009; van Nimwegen et al., 2014), obesity,(Guler et al., 2018; Nam et al., 2015), poor bone health (Gilsanz et al., 1990; Mostoufi-Moab et al., 2012; Petryk et al., 2006), impaired muscular and cardiorespiratory fitness (CRF) (Söntgerath and Eckert, 2015; van Brussel et al., 2005), or mental disorders, especially depression (Brinkman et al., 2016), have all been found to be higher among CCS than among healthy peers. However, no meta-analysis has yet compared the global health status of CCS and their controls.
Our objective was to conduct a systematic review and meta-analysis of case (CCS)-control studies to compare, from an integrative perspective, the health status of cancer-free CCS with their healthy counterparts. To this end, we studied those health-related parameters likely to be most affected by disease or its treatment considering the aforementioned health conditions more prevalent in CCS, including cardiovascular and pulmonary function, body composition, metabolic and inflammatory markers, physical capacity phenotypes (e.g., CRF, muscular strength), physical activity levels, fatigue, and mental health.
Section snippets
Patients and methods
This review is registered in PROSPERO (CRD42018108643). We followed the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) (Moher et al., 2009) and the Meta-analysis of Observational Studies in Epidemiology (MOOSE) (Stroup et al., 2000) statements (see the checklists in Supplementary Files 1 and 2, respectively).
Results
From the retrieved articles, 86 (Akyay et al., 2014; Al-Tawil et al., 2015; Alehan et al., 2012; Bell et al., 2006; Beulertz et al., 2016; Bianco et al., 2014; Brennan et al., 2005; Cantrell and Posner, 2014; Christiansen et al., 2014, 2016a; Christiansen et al., 2016b; De Caro et al., 2006, 2011; Elbl et al., 2003, 2006; Esbenshade et al., 2014; Follin et al., 2011; Frisk et al., 2012a, b; Frisk et al., 2012c, 2011; Ganame et al., 2007; Garmey et al., 2008; Genberg et al., 2015; Gilsanz et
Discussion
Our results indicate that CCS have lower left ventricular function (lower LVEF and FS), higher levels of a central adiposity indicator (waist-to-hip ratio) and lower HDL-cholesterol levels when compared with their healthy counterparts with no prior history of cancer. To the best of our knowledge, this is the first meta-analysis compiling CCS data for different health-related endpoints, including cardiac and pulmonary function, body composition, metabolic syndrome indicators, biochemical
Funding source
This work was supported by the Spanish Ministry of Education, Culture and Sport (contract number FPU14/03435 and FPU16/03956 to JSM and CRC, respectively); University of Alcalá (contract number FPI2016to PLV]; Universidad Europea de Madrid [2017/UEM14 and 2018/UEM02); Cátedra Real Madrid–Universidad Europea (2017/RM05); the Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias and Fondos FEDER, grant numbers PI15/00558 and PI18/00139 to Lucia), the Spanish
Declaration of Competing Interest
The authors report no conflict of interest.
Javier S. Morales, MSc, is a PhD candidate in exercise physiology and researcher at the European University of Madrid (Spain). His main research interest is the application of exercise physiology in cancer research (adults, adolescents and children in general).
References (140)
- et al.
Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice
Int. J Cardiol.
(2005) - et al.
Left ventricular function in long-term survivors of childhood lymphoma
Am J Cardiol.
(2014) - et al.
Utility of global longitudinal strain by echocardiography to detect left ventricular dysfunction in Long-term adult survivors of childhood lymphoma and acute lymphoblastic leukemia
Am J Cardiol.
(2016) - et al.
Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients
J Am Soc. Echocardiogr.
(2007) - et al.
Osteoporosis after cranial irradiation for acute lymphoblastic leukemia
J Pediatr
(1990) - et al.
New three-dimensional speckle-tracking echocardiography identifies global impairment of left ventricular mechanics with a high sensitivity in childhood cancer survivors
J Am Soc. Echocardiogr.
(2013) - et al.
Cardiovascular responses to dynamic submaximal exercise in children previously treated with anthracycline
Am Heart J
(1997) - et al.
Dobutamine stress echocardiography: a sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer
J Am Coll. Cardiol.
(1992) - et al.
No excess fatigue in young adult survivors of childhood cancer
Eur J Cancer
(2003) - et al.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
J Clin. Epidemiol
(2009)
Energy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia
Blood
Exercise capacity in young adults after hematopoietic cell transplantation in childhood
Am J Transpl.
Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy
J Clin. Oncol.
Muscle strength, motor performance, cardiac and muscle biomarkers in detection of muscle side effects during and after acute lymphoblastic leukemia treatment in children
J Pediatr Hematol Oncol.
Tissue Doppler evaluation of systolic and diastolic cardiac functions in long-term survivors of Hodgkin lymphoma
Pediatr Blood Cancer
Lipid profile and hepatic steatosis in hepatitis C infected egyptian survivors of childhood cancer
Pediatr Hematol Oncol.
Stand. Deviations Stand. Errors
BMJ
Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study
J Clin. Oncol.
Development and validation of MIX: comprehensive free software for meta-analysis of causal research data
BMC Med. Res. Methodol.
Perception of effort at low and moderate intensity exercise in survivors of childhood acute lymphoblastic leukaemia
Ann. Hum. Biol
Limitations in ankle dorsiflexion range of motion, gait, and walking efficiency in childhood cancer survivors
Cancer Nurs.
Evaluation of fitness levels of children with a diagnosis of acute leukemia and lymphoma after completion of chemotherapy and autologous hematopoietic stem cell transplantation
Cancer Med.
Aerobic exercise and cardiopulmonary fitness in childhood cancer survivors treated with a cardiotoxic agent: a meta-analysis
Support Care Cancer
Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation
J Clin. Endocrinol. Metab.
Behavioral, social, and emotional symptom comorbidities and profiles in adolescent survivors of childhood cancer: A report from the childhood cancer survivor study
J Clin. Oncol.
Precision medicine in pediatric oncology
Mol. Cell. Pediatr
Psychological distress between young adult female survivors of childhood cancer and matched female cohorts surveyed in the adolescent health study
Cancer Nurs.
Fatigue in cancer patients compared with fatigue in the general United States population
Cancer
Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart
Am J Physiol Regul. Integr. Comp. Physiol
Long-Term Follow-up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers Version 4.0
Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia
Eur Heart J Cardiovasc. Imaging
Exercise capacity in apparently healthy survivors of cancer
Arch Dis. Child.
Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors
Pediatr Blood Cancer
Risk and impact of pulmonary complications in survivors of childhood cancer: A report from the childhood cancer survivor study
Cancer
High-intensity interval training interventions in children and adolescents: A systematic review
Sports Med.
The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography
Neoplasma
Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up
Support Care Cancer
Screening for vitamin D insufficiency in pediatric cancer survivors
Pediatr Blood Cancer
Bone loss after childhood acute lymphoblastic leukaemia: an observational study with and without GH therapy
Eur J Endocrinol.
Effects of a high vs moderate volume of aerobic exercise on adiposity outcomes in postmenopausal women: A randomized clinical trial
JAMA Oncol.
Glucose metabolism and body composition in young adults treated with TBI during childhood
Bone Marrow Transpl.
A longitudinal study of pulmonary function after stem cell transplantation, from childhood to young adulthood
Pediatr Blood Cancer
Risk factors for cardiovascular disease are increased in young adults treated with stem cell transplantation during childhood
Pediatr Transpl.
Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D
Bone Marrow Transpl.
Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study
J Clin. Oncol.
Cardiac function after hematopoietic cell transplantation: an echocardiographic cross-sectional study in young adults treated in childhood
Pediatr Blood Cancer
Prevalence of hypertension determined by ambulatory blood pressure monitoring (ABPM) and body composition in long-term survivors of childhood cancer
Pediatr Hematol Oncol.
Health-related fitness in very long-term survivors of childhood cancer: A cross-sectional study
Pediatr Blood Cancer
Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography
Eur J Pediatr
Obtaining standard errors from confidence intervals and P values: absolute (difference) measures
Cited by (0)
Javier S. Morales, MSc, is a PhD candidate in exercise physiology and researcher at the European University of Madrid (Spain). His main research interest is the application of exercise physiology in cancer research (adults, adolescents and children in general).
Pedro L. Valenzuela, MSc, is a PhD candidate in exercise physiology and researcher in the Physiology Unit of Univerty of Alcalá (Spain). His main research interest is the application of exercise physiology in both clinical populations and athletes.
Cecilia Rincón-Castanedo, MSc, is a PhD candidate in physical activity and exercise and researcher at the European University of Madrid (Spain). His main research interest is the application of exercise physiology in cancer research (both human and childhood cancers in general, including animal models).
Alejandro Santos-Lozano, PhD. is the head of The Department of Health Sciences at European University Miguel de Cervantes, Valladolid, Spain. His main research area (+90 papers in peer-review journals) includes epidemiology and clinical aspects and benefits of physical activity (or ‘exercise’); particularly in special population including cancer survivors.
Carmen Fiuza-Luces, PhD, works with a post-doctoral research contract at the Hospital 12 de Octubre (‘i+12’) Research Institute (Madrid, Spain). She is actively involved in cancer research (both human [leukemia] and childhood cancers in general, including animal models).
Alejandro Lucia, MD, PhD, is a professor in Exercise Physiology and senior researcher at the European University and Hospital 12 de Octubre (‘i+12’) Research Institute, both in Madrid, (Spain). His main research interests are exercise effects in disease conditions and populations, including childhood cancer survivors.
- 1
These two authors have contributed equally to this work.